Search Share Prices
AZN News - Jefferies Financial Group Reiterates “GBX 8,100” Price Target for AstraZeneca PLC (AZN.L) (LON:AZN)
AstraZeneca PLC (AZN.L) (LON:AZN) has been given a GBX 8,100 ($105.83) price target by research analysts at Jefferies Financial Group in a research report issued to clients and investors on Monday, ...
AstraZeneca says coronavirus vaccine is 90% effective in one dosing regimen
AstraZeneca PLC announced that the coronavirus (COVID-19) vaccine it has developed with Oxford University is 90% effective in one of the dosing regimens. An independent monitoring ...
Berenberg Bank Reaffirms Buy Rating for AstraZeneca PLC (AZN.L) (LON:AZN)
Berenberg Bank restated their buy rating on shares of AstraZeneca PLC (AZN.L) (LON:AZN) in a report released on Thursday, AnalystRatings.net reports. Several other research firms have also commented ...
AstraZeneca’s Imfinzi (durvalumab) approved in the US for new four-week 1,500mg fixed-dosing option
AstraZeneca (LON: AZN), a global, science-led biopharmaceutical company, has announced the US Food and Drug Administration (FDA) approval of its Imfinzi (durvalumab) for an additional dosing option, a ...
AstraZeneca says Imfinzi cancer treatment approved for less frequent dosing option
AstraZeneca PLC has announced that its Imfinzi cancer treatment has been approved in the US for an additional dosing option, a 1,500 milligrams (mg) fixed-dose every four weeks, i ...